Objectives

1. Describe risk stratification and long-term follow up for Pheochromocytoma and Paraganglioma
2. Describe workup and management of Pheochromocytoma and Paraganglioma
3. Identify gene mutations associated with Pheochromocytoma and Paraganglioma

4. Describe the roles of the members of the health care team in their respective responsibilities for quality care

Faculty

Marat Abdullin, MD
Nephrologist